SYS6043 Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 1Phase 1/2: 2

Top Sponsors

Conjupro Biotherapeutics, Inc.1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
CSPC Megalith Biopharmaceutical Co.,Ltd.1

Indications

Cancer3
Advanced Metastatic Cancer1
Prostate1
Advanced/Metastatic Solid Tumors1
Solid Tumor Cancer1

Other2 trials

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

Phase 1/2

Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

Phase 1/2

Plantation, Florida1 trial

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

BRCR Global

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.